LONDON, 2025 — Claritas Intelligence has published its global market report on the cosmetics safety assessment industry, sizing the market at USD 3.1 billion in 2025 and projecting — on a base-case model — growth to USD 4.8 billion by 2033, representing a 5.6% CAGR over the 2025–2033 forecast period.
The most immediate demand catalyst in the United States is MoCRA, signed into law in December 2022 as the first substantive federal cosmetics legislation since the FD&C Act of 1938. Mandatory facility registration and product listing requirements have brought an estimated 10,000-plus cosmetics facilities under FDA oversight for the first time. Serious adverse-event reporting (within a 15-business-day window) and FDA's new recall authority create ongoing post-market surveillance obligations that translate directly into documented third-party safety assessment programs. Each discrete requirement generates incremental spend on dossier preparation, compliance audits, and post-market surveillance services. The report's contrarian note is worth flagging: the base case assigns material probability to MoCRA guidance delays extending beyond 2026, which could defer an estimated USD 200–300 million of anticipated compliance testing spend by 12–18 months — a scenario the report argues is underweighted by market consensus.
Europe retains the largest regional share. The EC 1223/2009 framework's requirement for a Cosmetic Product Safety Report signed by a qualified safety assessor for every SKU on the EU market provides a structurally non-cyclical revenue floor for testing bodies and specialist dermatological labs. The EU's comprehensive animal-testing ban, reinforced through REACH restriction dossiers and continuously updated OECD test guidelines (TG 439, 442C/D, 492), has made validated in vitro alternatives the global default for compliant brands — and the fastest-growing service sub-segment in the report. Reconstructed human epidermis assays and high-content screening are the primary growth formats within non-animal testing methods, pulled by clean beauty brand demand and EU compliance requirements in roughly equal measure. The FTC's updated Green Guides and the EU's proposed Green Claims Directive (2023) are adding a separate layer of claims-substantiation audit demand that operates independently of product launch cycles.
Asia Pacific is the report's fastest-growing region. China's NMPA pivot under CSAR 2021 — accepting OECD-validated in vitro alternatives for imported general cosmetics, phased from 2021 — represents the most significant structural shift in global cosmetics regulation in a decade. Multinational brands seeking CFDA filing must now generate alternative-method safety data packages, concentrating incremental demand in Asia Pacific contract labs carrying NMPA-accepted accreditation. SKU proliferation driven by TikTok Shop and DTC platform expansion is amplifying near-term volume, as indie and creator-led entrants disproportionately lack in-house regulatory capability and default to outsourced testing services.
"The MoCRA enforcement ramp and China's animal-alternative pivot are the two structural breaks that matter most over the next three years. What the consensus misses is that AI-assisted formulation screening is already compressing early-stage ingredient hazard assessment timelines by an estimated 30–40%, which threatens commoditization at the entry tier even as the total addressable market expands. The labs that hold pricing power will be those with OECD-validated, NMPA-accepted in vitro methods — not broad-based volume testers." — Ishani Das, Claritas Intelligence
The report covers leading operators across the testing and CRO ecosystem, including Eurofins Scientific SE, SGS SA, Intertek Group plc, Bureau Veritas SA, Charles River Laboratories International, TÜV SÜD AG, Covance Inc. (a LabCorp subsidiary), Toxikon Corporation, Pacific BioLabs, IQVIA Holdings Inc., Mérieux NutriSciences Corporation, and BioScreen Testing Services.
About Claritas Intelligence: Claritas Intelligence is a global market intelligence publisher covering high-growth industries across technology, consumer goods, life sciences, and industrials. Its research serves strategy teams, investors, and senior operators who require precise, primary-sourced market analysis.
The full analysis, including segmentation, regional breakdowns, forecasts, and company profiles, is available in the Cosmetics Safety Assessment Market Report.
“The global cosmetics safety assessment market is estimated at USD 3.1B in 2025 and, on a base-case projection, reaches USD 4.8B by 2033 at a 5.6% CAGR, driven by MoCRA enforcement and EU compliance demand.”
Ishani Das
Manager – Consumer Goods